Background: Development of resistant variants to existing antifungal drugs continues to be the serious problem in Candida albicans-induced fungal pathogenesis, which has a considerable impact on animal and human health. Identification and characterization of newer drugs against C. albicans is, therefore, essential. MMGP1 is a direct cellpenetrating peptide recently identified from marine metagenome, which was found to possess potent antifungal activity against C. albicans.
Introduction
Fungal disease, in a majority of the cases, in immunocompromised individuals is caused by the opportunistic fungal pathogen, Candida albicans. The increasing incidence of candidiasis and a rapid acquisition of drug resistance by C. albicans to the conventional antifungal drugs necessitate the development of novel anticandidal drug [1] . The therapy involving antimicrobial peptides (AMPs) has received greater attention in recent years as pathogenic microorganisms are less likely to develop resistance to these peptides [2] .
The mechanism of action of antifungal peptides involves membrane permeabilization/translocation, inhibition of cellular processes and formation of reactive oxygen species (ROS) in the fungal species [3] . AMPs have been known to translocate across the cell membrane and exert antimicrobial action by affecting macromolecular processes such as protein, nucleic acid and cell wall synthesis and enzyme activities [4] . The formation of ROS has been suggested to play a pivotal role in the fungicidal activity of most of the antifungal peptides. Certain antifungal peptides such as papillocin [5] , mellitin [6] , histatin 5 [7] , lactoferrin [8] , pleurocidin [9] exhibit anticandidal activity by inducing apoptosis. Fungicidal activity of other antifungal peptides such as LL-37 [10] , PAF26 [11] , lactoferrin and histatin5 [12] is caused by their binding with nucleic acids. Recently, in our laboratory, we have identified a novel peptide [MLWSASMRIFASAFSTRGLGTRMLMYCSLPSRCWRK (MMGP1)] from marine metagenome, which exhibited chitin binding and direct cell-penetrating property and was found to possess potent antifungal activity against C. albicans and A. niger. The minimum inhibitory concentration of the peptide was reported to be 0.57 µM for C. albicans and 4.29 µM for A. niger [13, 14] . The mechanism of action this peptide in exhibiting antifungal activity remains unexplored. Hence, we investigated the mechanism of antifungal action of MMGP1 in C. albicans in this study.
Materials and Methods

Ethics Statement
The blood sample for hemolytic activity assay was collected from a healthy individual with written consent after the approval of Internal Research Review Board and Ethical Clearance Committee of Madurai Kamaraj University.
Peptide synthesis
MMGP1 peptide was synthesized with >98% purity employing solid phase methods using N-(9-fluorenyl) methoxycarbonyl (Fmoc) chemistry (Genscript Corporation, Piscataway, NJ, USA). The peptide (5 mg) was dissolved in 1 ml of 50 mM Tris buffer (pH 7.4) and appropriately diluted sample was used for subsequent analysis.
Cell treatment and microscopic analysis
In all experiments, the C. albicans cells were treated with a determined minimum inhibitory concentration (0.57 µM) of MMGP1 for different time intervals at 30°C. The C. albicans cells treated with 1 mM of H 2 O 2 were used as a positive control. For fluorescence microscopic analysis, the treated cells stained with fluorescent probe at respective time intervals were collected by centrifugation at 10,000 × g for 10 min; subsequently the cells were washed with phosphate-buffered saline (PBS) and examined under Nikon Eclipse Ti fluorescence microscope (Nikon, Tokyo, Japan).
DNA binding assay
The plasmid DNA Bluescript II SK (+) was purified using a QIAprep Spin Minprep kit (Qiagen, Germay) and used for subsequent analysis. The plasmid DNA (100 ng) was mixed with varying concentrations of peptide such as 0.036, 0.072, 0.144, 0.288 and 0.576 µM, respectively, in 20 µl of HBS (21 mM Hepes-NaOH buffer containing 135 mM NaCl, 5.0 mM KCl and 0.76 mM Na 2 HPO 4, pH 7.4) buffer and the mixture was incubated at room temperature for 30 min and then subjected to electrophoresis on 1% agarose gel.
Fluorescence quenching assays
All fluorescence measurements were carried out in 96-well black bottom microtitre plates using SpectraMax ® e microplate reader (Molecular Devices, CA, USA). The changes in the tryptophan fluorescence of MMGP1 on addition of plasmid DNA were recorded using the method described by Hsu et al., (2005) [15] . The plasmid DNA (100 ng) was incubated with varying concentrations of peptide as described previously for 30 min at room temperature. The emission spectra were recorded from 300 to 400 nm with an excitation wavelength of 295 nm. The fluorescence spectra were determined for peptide alone or in the presence of different concentrations of plasmid DNA. Further, the fluorescence quenching of SYTO 9 was measured at varying concentrations of the peptide as described previously. The plasmid DNA was incubated with varying concentrations of peptide for 30 min at room temperature to allow for the formation of the DNA-peptide complex. SYTO 9 dye was added to the formed complexes at a final concentration of 5 µM and was incubated for 30 min at room temperature under total darkness. After incubation, the fluorescence quenching of SYTO 9 dye was measured at an excitation wavelength of 485 nm and emission wavelength of 498 nm.
DNase I protection assay
The DNase I protection assays were performed as per the protocol described by Niiodme et al., (1997) [16] . The assay were performed by mixing 100 ng of the plasmid DNA (blue script SK+) with varying concentrations of peptides as described previously, in 45 µl of HBS and incubated for 30 min at room temperature. After incubation, 5 µl solution of 10 mM MgCl 2 and 10 mM CaCl 2 were added to the mixture, followed by addition of 5 µl of 0.5 mg/ml DNase I (Sigma Aldrich, CA, USA) in water and the solution was incubated at 42°C for 30 min. To dissociate the plasmid DNA bound to the peptide, 2 µl of proteinase K (20 mg/ml) was added and the solution incubated at 55°C for 30 min. After incubation, the mixture was electrophoresed on 1% agarose gel.
In vitro transcription experiment
The inhibition of transcription by MMGP1 was studied in vitro using MAXIscript T7 in vitro transcription kit (Invitrogen, USA). The pTRI-actin control template harbouring mouse β-actin gene with T7 promoter was mixed with varying concentrations of peptide (0.036, 0.072, 0.144, 0.288 and 0.576 µM) for 30 min at room temperature. In vitro transcription reactions were performed individually for the control templates treated with different concentrations of peptide for 1 h at 37°C. After transcription reaction, 1 µl of TURBO DNase was added to the mixture and it was incubated at 37°C for 10 min to remove the control template DNA. The transcribed product of 304 bases were analysed on 5% denaturing polyacrylamide gel. The transcripts level was quantified by gel densitometry analysis using gel imaging system (Bio-Rad, USA).
In vivo transcription assay
The inhibition of transcription by MMGP1 in C. albicans was studied based on the biosynthetic incorporation of the uridine analog 5-ethynyluridine (EU) into the newly transcribed RNA as described by Jao and Salic, (2008) [17] . The C. albicans cells were grown in potato dextrose broth (PDB) in the presence of EU (1 mM) for 6 h at 30°C and subsequently, treated with MMGP1 (0.57 µM) for 0, 2, 6, 12 and 24 h and collected by centrifugation at 10, 000 × g for 10 min. The collected cells were rinsed and fixed in PBS with 0.5% formaldehyde and 0.5% Triton-X-100 for 30 min at room temperature. For EU detection, the cells were rinsed with Tris-buffered saline (TBS) and stained with 100 mM Tris (pH 5.8)/1 mM CuSO 4 /25 µM tetramethyl rhodamine-azide (TMR-A)/100 mM ascorbic acid for 30 min at room temperature. After staining, the cells were collected and washed thrice with TBS containing 0.5% Triton X-100 and counter-stained with Hoechst 33342 (5µM) for 30 min at room temperature under darkness. The cells were examined under Operatta High content imaging system (PerkinElmer, Massachusetts, USA).
ROS imaging and quantification
The endogenous production of ROS in C. albicans cells was analyzed after its 6 h treatment with MMGP1 or H 2 O 2 by 2', 7'-dichlorodihydrofluorescein diacetate (H 2 DCF-DA) staining followed by fluorescence microscopy [18] . For quantitative assessment of ROS production, the population of cells exhibiting dichlorofluorescein (DCF) fluorescence were measured at 1, 3 and 6 h of treatment with the peptide using flow cytometry.
Viability assay
Time-kill experiment for antifungal activity was performed turbidimetrically with supplementation of glutathione, an antioxidant. The exponentially growing cultures of C. albicans were treated with peptide in the presence of different concentrations of glutathione (1, 10 and 50 mM) for 24 h. The absorbance at 600 nm was measured at 6, 12, 18, and 24 h using SpectraMax ® e microplate reader. The culture without peptide was used as a control.
Measurement of protein oxidation
Intracellular oxidation of proteins in C. albicans could be determined by measuring the carbonyl groups generated in some amino acid side chains using dinitophenylhydrazine (DNPH) derivatization method [19] . The level of protein carbonyls in MMGP1-or H 2 O 2 -treated cells were measured for 24 h. At every 6 h of treatment, 500 µl of cells were collected and the cell lysates were prepared by ultrasonication. The protein present in the cell lysates were quantified using Lowry's method. Protein samples (250 µl; 12.4 mg/ml) were incubated with or without DNPH solution (1 ml) for 45 min at room temperature in dark with intermittent gentle mixing. The reaction mixture was added to 1.25 ml of 10% trichloroacetic acid solution and incubated on ice for 10 min. After incubation, the suspension was centrifuged at 10,000 × g for 10 min at 4°C and the supernatant fraction was discarded. The pellet was washed five times with 1 ml of ethanol/ethyl acetate (1: 1 v/v) and resuspended in 250 µl of 50 mM Tris-HCl (pH 7.4) buffer and incubated for 10 min at 37°C. The solubilized protein in the buffer was quantified prior to assay. The supernatant fraction was transferred to a minicuvette and the absorbance was measured at 375 nm using spectrophotometer (Hitachi U-2900, Tokyo, Japan). Protein carbonylation was determined as follows: protein carbonyls (nmol/ml) = A 375nm × 45.45 (nmol/ml); protein carbonyl (nmol/mg) = protein carbonyl (nmol/ml) / protein concentration (mg/ml).
Measurement of lipid peroxidation
The MMGP1-induced oxidation of lipids in C. albicans was determined by quantitative measurement of thiobarbituric acid (TBA) -reactive substances (TBARS) [20] . The production of TBARS in MMGP1-or H 2 O 2 -treated cells was measured for 24 h. At every 6 h of treatment, 500 µl of cell suspension was removed and the cells were collected by centrifugation at 10,000 × g for 10 min. The cell pellet was washed twice with 500 µl of sterile distilled water and resuspended in same volume of sterile distilled water. To the cell suspension, 1 ml of TBA reagent (0.25 M HCl, 15% [w/vol] trichloroacetic acid, 0.375% [w/vol] TBA) was added and the reaction was terminated. The mixture was boiled at 100°C for 15 min in a water bath and allowed to cool at room temperature. Cell debris was removed by centrifugation at 3000 × g for 5 min and the TBARS was assayed in the supernatant at 535 nm. TBA reagent mixed with 0.5 ml of distilled water was used as the blank. The concentration of TBARS in the samples was determined against the reference tetraethoxypropane.
Determination of mitochondrial membrane potential
The mitochondrial membrane potential in MMGP1-treated C. albicans cells were analyzed by rhodamine 123 staining followed by flow cytometry analysis. Rhodamine 123 is a cellpermeant cationic fluorescent dye sequestered by active mitochondria. The fluorescence quenching of rhodamine 123 directly depends upon the electrochemical gradient across the mitochondrial membrane [21] . Mitochondrial membrane potential in MMGP1-treated C. albicans cells was measured for 24 h. At every 6 h of treatment, the cells were collected by centrifugation at 10,000 × g for 10 min and subsequently stained with 100 nM of Rhodamine 123. The population of cells exhibiting green fluorescence was quantified using flow cytometry.
Further, the depolarization of inner mitochondrial membrane in MMGP1-treated C. albicans cells was assessed by cardiolipin-specific nonyl acridine orange (NAO) staining [22] . The C. albicans cells were grown in 500 ml of potato dextrose broth in the presence or absence of peptide for 24 h at 30°C. The treated and untreated cells were collected by centrifugation at 500 × g for 10 min; subsequently the cells were washed twice with distilled water and once with 1 M sorbitol. The cells were resuspended in 5 ml of spheroplasting buffer (1 M sorbitol, 25 mM EDTA, 100 mM Na-citrate [pH 5.8]) along with lyticase (2.5 mg per g [wet weight] of yeast cells) and incubated for 2 h at 30°C with gentle shaking. The osmotically sensitive cells were lysed using 10% sodium dodecyl sulphate (SDS). The spheroplast obtained was centrifuged at 500 × g for 5 min and washed twice with 1 M sorbitol. The cells were then resuspended in 5 ml of ice cold breaking buffer (0.6 M sorbitol, 20 mM HEPES, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride [pH 7.4]) and homogenized in a glass homogenizer on ice. The homogenized mixture was centrifuged at 500 x g for 5 min at 4°C and the pellet fraction was discarded. The supernatant fractions containing mitochondria were collected and centrifuged at 12,000 × g for 15 min at 4°C, and the pellet fraction was resuspended in osmotic buffer (10 mM Tris-HCl, 0.6 M mannitol, 2 mM EGTA [pH 6.8]). The mitochondria in osmotic buffer were stained with NAO for 20 min in total darkness at room temperature. The fluorescence quenching of NAO by mitochondria was visualized under fluorescence microscope at an excitation wavelength of 485 nm and emission wavelength of 530 nm.
DNA fragmentation assay
The MMGP1-induced DNA damage in C. albicans was assessed by terminal deoxynucleotidyl transferase (TdT)- 
Hemolytic activity assay
The hemolytic activity of the MMGP1 was determined on 1% human red blood cells. Freshly collected blood cells were washed in PBS (pH 7.4) and finally resuspended in four times their original volume of PBS. A 50 µl of 1% HRBC suspension was aliquoted into wells of 96-well microtiter plates, and the peptide was added to the suspension at a final concentration of 0.37, 0.74, 1.48, 2.96, 5.92, 11.84, 23.68, 47.36 µM to a final volume of 100 µl. Samples were incubated at 37°C for 1 h and centrifuged at 1400 × g for 10 min, and the supernatant was transferred to fresh 96-well microtiter plates. The hemoglobin release was monitored by measurement of absorbance at 540 nm with a SpectraMax ® e microplate reader. The hemolytic activity of MMGP1 was calculated as the percentage of total hemoglobin released compared with that released by incubation with 0.1% Triton X-100 by using the following formula: % hemolysis = (A540nm in the peptide solutionA540nm in PBS) / (A540nm in 0.1% Triton X-100 -A540nm in PBS) × 100.
Flow cytometry analysis
MMGP1-induced ROS production, mitochondrial membrane damage, DNA damage and transcription inhibition in C. albicans was measured by flow cytometry [10,000 cells were gated for ROS induction, mitochondrial and DNA damage experiments, whereas, 50,000 cells were gated for transcription inhibition assay on live cells by Forward scatter (FSC)/Side scatter (SSC)] using fluorescence activated cell sorter (FACSAria III, Beckton Dickinson, San Jose, CA, USA). For measurement of MMGP1-induced ROS production, mitochondrial membrane damage and DNA damage in C. albicans cells, the treated cells were stained with H 2 DCF-DA, rhodamine123 and fluorescein-12-dUTP, respectively, at different intervals, for 30 min at room temperature. The stained cells were collected by centrifugation at 10,000 × g for 10 min; subsequently the cells were washed with 500 µl of PBS and resuspended in the same volume of PBS. The population of cells exhibiting green fluorescence was quantified using FACS at 488 nm employing a blue laser with emission in the 530⁄30 band pass filter. For in vivo transcription inhibition assay, the EU labelled cells after treatment with MMGP1 was stained with TMR -azide as described previously. The population of cells with red fluorescence was quantified using FACS at 630 nm employing a green laser with emission in the 610/20 nm band pass filter. The analysis of the results was carried out using FACSDiva version 6.1.3 software (Beckton Dickinson).
Results
DNA-binding ability of MMGP1
The DNA-binding ability of the peptide was evaluated by agarose gel electrophoresis (Figure 1a & 1b) . At peptide concentrations of 0.036 and 0.072 µM, the plasmid DNA migrates and stains normally in gel as non-complexed DNA. More than 40% of the plasmid DNA remains unbound at a concentration of 0.288 µM, whereas, at a higher peptide concentration (0. 576 µM), no DNA bands were detected on the gel, showing the intrinsic DNA-binding ability of MMGP1.
Fluorescence Quenching
The intrinsic tryptophan fluorescence spectra were used to ascertain the conformational changes and the interactions between DNA and MMGP1, since the intensity and the emission maximum depend on the surrounding environment of the indole ring of the tryptophan residue. The MMGP1 peptide contains two tryptophan residues and the DNA binding is expected to change the polarity of the environment around these residues. The modification of fluorescence spectra of tryptophan on the addition of different concentrations of plasmid DNA is shown in Figure 2a . The results revealed that in the absence of DNA, MMGP1 exhibited a fluorescence emission maximum at 330 nm, and addition of DNA caused the fluorescence intensity to decrease and the emission maximum to shift from 330 nm to 310 nm, indicating that the conformational changes had occurred in the environment of tryptophan residues on DNA binding. Furthermore, we also examined the fluorescence quenching of SYTO 9 at varying concentrations of peptide as shown in Figure 2b . The results revealed that in the absence of the peptide, an enhanced fluorescence of the SYTO 9 probe was observed. Fluorescence intensity of SYTO 9 decreased with a further increase in the peptide concentration and at a higher concentration of peptide (0.576 µM), no fluorescence of the probe was observed, which clearly indicates that the binding of peptide with DNA prevents the intercalation of the probe into nucleotide bases.
DNase I protection assay
The formation of DNA-peptide complexes was confirmed by treating the formed complexes with proteinase K, which showed detection of bound plasmid DNA in agarose gel ( Figure  3a) . The DNA-binding ability of the peptide was evaluated by studying the inhibitory activities of the nuclease. The binding of peptide with plasmid DNA affords protection of DNA from nuclease activity as shown in Figure 3b . The DNA bands were prominent on the gel at a peptide concentration of 0.576 µM, whereas a small fraction of plasmid DNA was subjected to nuclease digestion at a peptide concentration of 0.288 µM. However, digestion of DNA by the DNase1 took place without resistance at the lesser peptide concentration, indicating that MMGP1 had the strongest DNA-binding ability to plasmid DNA. These findings were consistent with the results from the DNAbinding assay as described above.
Transcription inhibition by MMGP1
The inhibition of transcription by MMGP1 was studied at varying peptide concentrations under in vitro conditions. Figure  4a & 4b shows the in vitro expression level of mouse β-actin gene in the presence of varying concentrations of MMGP1. No inhibition of transcription was observed at lesser peptide concentrations. The transcription reaction was found to be significantly inhibited (78%) at a higher peptide concentration (0.576 µM). The in vivo transcription inhibition by MMGP1 in C. albicans was studied based on the biosynthetic incorporation of EU into nascent RNA. At 2 h of incubation, intense EU staining (red fluorescence) was observed in the nucleus, which indicates the active incorporation of EU into the cells i.e., active transcription, whereas, EU signals in the nucleus dropped dramatically after 6 h of incubation (Figure 5a ). Flow cytometry analysis also confirmed that transcription was not inhibited at 2 h of incubation, whereas only 8.62% and 3.99% of cells showed EU signals after 6 and 12 h of incubation, respectively (Figure 5b) . Thus, the peptide inhibits the transcription in vivo in C. albicans.
Endogenous ROS production
MMGP1-induced endogenous production of ROS in C. albicans was analyzed by H 2 DCF-DA staining. H 2 DCF-DA is a cell-permeant and indicator of ROS, which is non-fluorescent until the acetate groups are removed by oxidation occurring within the cells. MMGP1-treated cells showed intracellular production of ROS, which was inferred by the DCF fluorescence of cells due to the oxidation of H 2 DCF-DA probe (Figure 6a) . Quantification of endogenous ROS production in MMGP1-treated C albicans cells by flow cytometry revealed no significant increase in DCF fluorescence until 1 h of incubation with the peptide, whereas 45.5% of the cells showed DCF fluorescence after 3 h and more than 99% of the cells showed DCF fluorescence after 6 h of incubation with the peptide (Figure 6b ).
Viability changes on glutathione supplementation
The effect of MMGP1 on the viability of C. albicans cells after glutathione supplementation is shown in Figure 7 . No significant increase in the growth of C. albicans cells treated with MMGP1 in the absence of glutathione was observed, whereas the cells treated with MMGP1 in the presence of glutathione showed an increase in cell viability as glutathione concentration increases.
Oxidation of proteins and lipids
An irreversible oxidation of proteins and lipids is the secondary effect of ROS produced within the cells. These deleterious modifications of proteins and lipids have lethal effects on target cells and lead to cell death. Therefore, the oxidation of intracellular proteins by ROS was studied by the examination of the cell lysates of C. albicans cells treated with MMGP1 at different time intervals. The results clearly indicated a time-dependent increase in the level of protein carbonyls in the treated cells (Figure 8a ). In addition, the oxidation of lipids by ROS was investigated in MMGP1-treated C. albicans cells at different time intervals, and a time-dependent increase in production of TBARS was observed (Figure 8b ). These consistent increases in the level of protein carbonyls and TBARS concentration at different time intervals indicate that the peptide induced oxidation of proteins and lipids.
Disruption of mitochondrial membrane potential
Dissipation of mitochondrial membrane potential in C. albicans cells by MMGP1 treatment was clearly evident from flow cytometry analyses. After 6 h of treatment with MMGP1, 73% of cells exhibited rhodamine fluorescence, whereas 43.9% of cells exhibited fluorescence after 12 h and only 17% of the cells showed rhodamine fluorescence after 24 h of treatment, which clearly indicate that the mitochondrial membrane potential is lost in 82% of the cells on treatment with MMGP1( Figure 9a ). Figure 9b shows the NAO staining of mitochondria isolated from C. albicans treated with and without MMGP1. The intensity of NAO fluorescence diminished after 24 h of treatment with the peptide, suggesting the oxidation of inner mitochondrial protein cardiolipin, which could be attributed to the loss in mitochondrial respiratory potential.
DNA damage
The in vivo DNA damage in C. albicans was analysed by TUNEL staining. At 6 h of incubation with the peptide, no TUNEL positive nuclei (green fluorescence) were observed, whereas, the number of TUNEL positive nuclei increased after 12 and 24 h of treatment with the peptide (Figure 10a ). FACS analysis of TUNEL-stained MMGP1 treated C. albicans cells are shown in Figure 10b . No TUNEL-positive cells were observed after 6 h of treatment, whereas, 9.7% and 99.9% of TUNEL-positive cells were observed after 12 and 24 h of treatment, respectively, which is an indicative of DNA damage induced by MMGP1 in C. albicans.
Hemolysis
The hemolytic activity of the peptide against human erythrocytes is considered as the major index of toxicity toward human cells. Hemolysis was observed at a peptide concentration of 11.84 µM, which was relatively higher that the MIC of C. albicans.
Discussion
Earlier, it was reported in our laboratory that the MMGP1 peptide induces cell death in C. albicans cells in a nondisruptive manner through energy-independent direct penetration mechanism [12] . Several antifungal peptides are translocated across cell membrane and are found inside the cell, wherein they can induce various inhibitory activities, disrupting normal cell functions primarily not linked with cell penetration [4] . In the present study, we investigated the mechanisms of antifungal action of MMGP1 in C. albicans. The MMGP1 showed a remarkable non-specific DNA-binding property in vitro. The use of SDS or trypsin to remove the peptide allows the direct analysis of the status of bound DNA in the peptide-DNA condensate [23] . Similarly, in this study, proteinase K was used to hydrolyse the peptide and the bound plasmid DNA was detected on the gel, which confirms the formation of peptide-DNA complexes. The peptide formed highly stable complexes with DNA, which is resistant to high ionic conditions (i.e., 0.3 M of NaCl) (data not shown) and nuclease activity. In addition, the peptide inhibited the transcription processes both under in vitro and in vivo conditions, and therefore was found to interfere with cellular transcription process once inside the fungal cell. This finding is consistent with the earlier report on the antimicrobial peptide, indolicidin, which induces cytotoxicity in the target cells by binding to DNA and inhibition of macromolecular synthesis [15] .
The MMGP1 is also capable of inducing endogenous production of ROS in C. albicans, which could be attributed to its binding with DNA, thereby inhibiting the transcription process within the cells. The ROS production by MMGP1 triggers a cascade of events like protein carbonylation, lipid peroxidation, mitochondrial membrane depolarization and DNA fragmentation. An earlier report suggested that the production of reactive species at subtoxic concentrations regulate cell differentiation, proliferation, signal transduction and ion transport whereas excessive accumulation of ROS within the cells can cause damage to DNA, proteins and lipids, which lead to disorganization, dysfunction and damage of membranes and proteins. Specifically, the oxidation of lipids may cause impairment of membrane function, decreased fluidity, increased permeability to ions and potentially membrane rupture [24] [25] [26] . To examine the relationship between endogenous production of ROS and antifungal mechanism, we investigated the secondary effect of ROS production in C. albicans by MMGP1. The results suggested that the hyper-induction of ROS causes oxidation of proteins, lipids and induces DNA damage. Furthermore, the growth of the MMGP1-treated C. albicans cells recovered after supplementation with glutathione, suggesting that the endogenous production of ROS could be the major mechanism for antifungal action of MMGP1 in C. albicans.
Mitochondrial dysfunction due to depolarization of mitochondrial membrane is a marked characteristic of ROSmediated cytotoxicity. Interestingly, the results of mitochondrialmediated experiments suggested that the MMGP1 induced disruption of mitochondrial membrane potential in C. albicans by depolarization of inner mitochondrial membrane. This finding is consistent with the earlier report on the antimicrobial peptide, papiliocin, which induces cytotoxicity in C. albicans by disruption of mitochondrial integrity and consequent cell death [5] . Certain other antifungal peptides such as α-and θ-defensin, magainin, cathelicidin and histatin are known to disrupt the mitochondrial membrane potential and induce cytotoxicity in yeast cells [7, 27] .
To conclude, we have demonstrated the mechanism of the antifungal action of marine metagenome-derived cellpenetrating antifungal peptide, MMGP1, against C. albicans. The collective data presented in this study indicate that the peptide inside the target cell exerts antifungal action by binding with DNA and inhibiting transcription processes that trigger a series of events such as endogenous production of ROS; oxidation of proteins; lipid, DNA damage; and dissipation of mitochondrial membrane potential that eventually lead to cell death.
